Document is current

Any future updates will be listed below

Two year outcomes of as needed brolucizumab therapy in exudative age related macular degeneration with or without pachychoroid phenotype

Crossref DOI link: https://doi.org/10.1038/s41598-026-37591-y

Published Online: 2026-01-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark